The Role of HDL-C
Currently, dyslipidemia represents one of the most modifiable risk factors for CHD.1 Although the general approach to treatment has largely focused on LDL-C, evidence continues to accrue pointing to the importance of HDL-C in CHD risk reduction.2
The following pages provide an overview of the role of HDL-C in lipid management, as well as essential information about niacin safety and dyslipidemia. Additional and timely resources are also provided to keep your practice up-to-date.
Next: HDL: A Component in Lipid Management
References
1. Toth PP. High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies. Am J Cardiol. 2005;96(suppl):50K-58K.
2. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease - the Framingham Heart Study. Can J Cardiol. 1988;4(Suppl A):5A-10A.
